A spectrum of obesity requires precision

from pharmaphorum Podcast · host pharmaphorum

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.

Episode metadata supplied by the publisher feed · Published Jul 10, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

A spectrum of obesity requires precision

0:00 23:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 23 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on July 10, 2024.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!